Pang K S, Lee W F, Cherry W F, Yuen V, Accaputo J, Fayz S, Schwab A J, Goresky C A
Faculty of Pharmacy, University of Toronto, Ontario, Canada.
J Pharmacokinet Biopharm. 1988 Dec;16(6):595-632. doi: 10.1007/BF01062014.
The effect of hepatic blood flow on the elimination of several highly cleared substrates was studied in the once-through perfused rat liver preparation. A constant and low input concentration of ethanol (2.0 mM), [14C]-phenacetin and [3H]-acetaminophen (0.36 and 0.14 microM, respectively), or meperidine (8.1 microM) was delivered once-through the rat liver preparation in five flow periods (greater than 35 min each); control flow periods at 12 ml/min were interrupted by flow changes to 8 or 16 ml/min. The steady-state hepatic availabilities (F or outflow survivals) at 12 ml/min were ethanol, 0.075 +/- 0.038; [14C]-phenacetin, 0.15 +/- 0.059; [3H]-acetaminophen, 0.34 +/- 0.051; meperidine, 0.047 +/- 0.017. Flow-induced changes were different among the compounds: with reduced flow (8 ml/min), F was decreased for ethanol (0.061 +/- 0.032) and [3H]-acetaminophen (0.28 +/- 0.051), as expected, but was increased for [14C]-phenacetin (0.20 +/- 0.068) and meperidine (0.05 +/- 0.03); with an elevation of flow (to 16 ml/min), F was increased for all compounds, as expected of shorter sojourn times: ethanol, 0.13 +/- 0.065; [14C]-phenacetin, 0.22 +/- 0.062; [3H]-acetaminophen, 0.43 +/- 0.063; meperidine, 0.055 +/- 0.022. A marked increase in F for ethanol had occurred when flow changed from 12 to 16 ml/min due to nonlinear metabolism; the latter was confirmed by a reduction in the extraction ratios at increasing concentrations (1.8 to 11.4 mM); this condition was not present for the other compounds. In order to explain the observations, we used the multiple indicator dilution technique to investigate the flow-induced behaviors of tissue distribution spaces of vascular and intracellular references in the perfused rat liver preparation.
在一次性灌注大鼠肝脏制剂中研究了肝血流量对几种高清除率底物消除的影响。以恒定低输入浓度的乙醇(2.0 mM)、[14C] - 非那西丁和[3H] - 对乙酰氨基酚(分别为0.36和0.14 microM)或哌替啶(8.1 microM)在五个血流时间段(每个时间段大于35分钟)一次性通过大鼠肝脏制剂;12 ml/min的对照血流时间段被血流变化至8或16 ml/min打断。12 ml/min时的稳态肝可用性(F或流出存活率)分别为:乙醇,0.075±0.038;[14C] - 非那西丁,0.15±0.059;[3H] - 对乙酰氨基酚,0.34±0.051;哌替啶,0.047±0.017。不同化合物的血流诱导变化不同:血流降低(8 ml/min)时,乙醇(0.061±0.032)和[3H] - 对乙酰氨基酚(0.28±0.051)的F如预期降低,但[14C] - 非那西丁(0.20±0.068)和哌替啶(0.05±0.03)的F升高;血流升高(至16 ml/min)时,所有化合物的F如预期因停留时间缩短而升高:乙醇,0.13±0.065;[14C] - 非那西丁,0.22±0.062;[3H] - 对乙酰氨基酚,0.43±0.063;哌替啶,0.055±0.022。由于非线性代谢,当血流从12变为16 ml/min时,乙醇的F显著增加;后者通过浓度增加(1.8至11.4 mM)时提取率降低得到证实;其他化合物不存在这种情况。为了解释这些观察结果,我们使用多指示剂稀释技术研究了灌注大鼠肝脏制剂中血管和细胞内参考物组织分布空间的血流诱导行为。